Describe the process(es) your organization has in place to ensure that your engagement activities are consistent with your overall climate change strategy[…]We are members of FPMAJ (Federation of Pharmaceutical Manufacturers' Associations of Japan) and The Intravenous Solution Society to ensure that our views are reflected and that public policy is consistent with our strategy. In addition, to ensure consistency with industrial policy, we keep abreast of the latest information on climate change issues and public policy through seminars held by the government, Keidanren, FPMAJ, and other organizations, and report back to the Terumo Group EHS Committee. In addition, important issues are placed on the agenda of the Terumo Group EHS Committee and the Executive Management Meeting to ensure consistency with the Company's climate change strategy. As long as the above process is in place, no discrepancies are expected to arise. If a conflict arises between Terumo's policy and direction and the direction of each group, the EHS Committee will discuss the conflict, including a change in Terumo's direction, if necessary. Furthermore, if the direction is not in line with our strategy and is unacceptable, the committee will recommend a direction to each organization based on our thinking. Since 2020, we have also participated in the Japan Climate Initiative (JCI), a non-governmental actor. In January 2021, through JCI, we announced our support for a message calling for a 40-50% renewable electricity target for FY2030 in Japan's next Basic Energy Plan.